nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2020-2-4-11nnp-1297Research ArticleLECTURESЛЕКЦИЯCurrent approaches to diagnosing in intracerebral hemorrhageСовременные подходы к диагностике при внутримозговом кровоизлиянииКулешА. А.KuleshA. A.aleksey.kulesh@gmail.comФГБОУ ВО «Пермский государственный медицинский университет им. акад. Е.А. Вагнера» Минздрава РоссииРоссияAcad. E.A. Vagner Perm State Medical University, Ministry of Health of RussiaRussian Federation202016042020122411Copyright © Kulesh A.A., 20202020Кулеш А.А.Kulesh A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/1297внутримозговое кровоизлияниегипертензионное внутримозговое кровоизлияниецеребральная амилоидная ангиопатияоральные антикоагулянтыдиагностикаintracerebral hemorrhagehypertensive intracerebral hemorrhagecerebral amyloid angiopathyoral anticoagulantsdiagnosisReferencesAn SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6.An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019 Jul;19(7):679-694. doi: 10.1080/14737175.2019.1623671. Epub 2019 Jun 12.Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6.Парфенов ВА. Когнитивные нарушения после инсульта. Неврология, нейропсихиатрия, психосоматика. 2019;11(4):22-7. doi: 10.14412/2074-2711-2019-4-22-27Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6.O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019 Jul;19(7):679-694. doi: 10.1080/14737175.2019.1623671. Epub 2019 Jun 12.Tatlisumak T, Cucchiara B, Kuroda S, et al. Nontraumatic intracerebral haemorrhage in young adults. Review. Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9.Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019 Jul;19(7):679-694. doi: 10.1080/14737175.2019.1623671. Epub 2019 Jun 12.Gross BA, Jankowitz BT, Friedlander RM. Cerebral Intraparenchymal Hemorrhage:Parfenov VA. Poststroke cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):22-7. (In Russ.) doi: 10.14412/2074-2711-2019-4-22-27A Review. JAMA. 2019 Apr 2;321(13): 1295-1303. doi: 10.1001/jama.2019.2413.Parfenov VA. Poststroke cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):22-7. (In Russ.) doi: 10.14412/2074-2711-2019-4-22-27Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.van Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.Tatlisumak T, Cucchiara B, Kuroda S, et al. Nontraumatic intracerebral haemorrhage in young adults. Review. Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9.Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.Tatlisumak T, Cucchiara B, Kuroda S, et al. Nontraumatic intracerebral haemorrhage in young adults. Review. Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9.Калашникова ЛА, Гулевская ТС, Добрынина ЛА. Актуальные проблемы патологии головного мозга при церебральной микроангиопатии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(2):90-9.Gross BA, Jankowitz BT, Friedlander RM. Cerebral Intraparenchymal Hemorrhage: A Review. JAMA. 2019 Apr 2;321(13): 1295-1303. doi: 10.1001/jama.2019.2413.Кулеш АА, Дробаха ВЕ, Шестаков ВВ. Церебральная болезнь мелких сосудов: классификация, клинические проявления, диагностика и особенности лечения. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):4-17. doi: 10.14412/2074-2711-2019-3S-4-17Gross BA, Jankowitz BT, Friedlander RM. Cerebral Intraparenchymal Hemorrhage: A Review. JAMA. 2019 Apr 2;321(13): 1295-1303. doi: 10.1001/jama.2019.2413.Новосадова ОА, Григорьева ВН. Церебральная амилоидная ангиопатия и гипертензивная церебральная микроангиопатия. Дифференциальный диагноз. Неврологический вестник. 2019;51(2):72-9.Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.Остроумова ТМ, Остроумова ОД, Парфенов ВА. Ранние признаки поражения головного мозга как органа-мишени при артериальной гипертензии. Неврология, нейропсихиатрия, психосоматика. 2019; 11(3S):32-7.doi: 10.14412/2074-2711-2019-3S-32-37Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.Кулеш АА, Дробаха ВЕ, Собянин КВ и др. Роль церебрального резерва, оцененного с помощью диффузионно-взвешенной магнитно-резонансной томографии, в определении реабилитационного потенциала острого периода ишемического инсульта. Неврология, нейропсихиатрия, психосоматика. 2019;11(3):26-34. doi: 10.14412/2074-2711-2019-3-26-34van Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.Остроумова ТМ, Парфенов ВА, Остроумова ОД и др. Возможности метода бесконтрастной магнитно-резонансной перфузии для выявления раннего поражения головного мозга при эссенциальной артериальной гипертензии. Неврология, нейропсихиатрия, психосоматика. 2018;10(1):17-23. doi: 10.14412/2074-2711-2018-1-17-23van Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonancevan Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.Кулеш АА, Дробаха ВЕ, Шестаков ВВ. Геморрагические проявления церебральной амилоидной ангиопатии – от патогенеза к клиническому значению. Неврология, нейропсихиатрия, психосоматика. 2018;10(3):4-11. doi: 10.14412/2074-2711-2018-3-4-11Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Current problems of brain pathology in cerebral microangiopathy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(2):90-9. (In Russ.)Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Current problems of brain pathology in cerebral microangiopathy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(2):90-9. (In Russ.)Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Current problems of brain pathology in cerebral microangiopathy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(2):90-9. (In Russ.)Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.) doi: 10.14412/2074-2711-2019-3S-4-17Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.) doi: 10.14412/2074-2711-2019-3S-4-17Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.) doi: 10.14412/2074-2711-2019-3S-4-17Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Novosadova OA, Grigor'eva VN. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Differential diagnosis. Nevrologicheskii vestnik. 2019;51(2):72-9. (In Russ.)Янишевский СН. Внутричерепные кровотечения у пациентов, принимающих оральные антикоагулянты. Современные возможности терапии. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):82-8. doi: 10.14412/2074-2711-2019-3S-82-88Novosadova OA, Grigor'eva VN. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Differential diagnosis. Nevrologicheskii vestnik. 2019;51(2):72-9. (In Russ.)Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Novosadova OA, Grigor'eva VN. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Differential diagnosis. Nevrologicheskii vestnik. 2019;51(2):72-9. (In Russ.)Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.
The authors declare that there are no conflicts of interest present.